GMP | MHRA

Total Records 41 to 44 of 44

GMP Search Results
Certificate Number	GMPC or Non-compliance	Site Details	Country	Inspection Date Sort ascending
UK GMP 20375 Insp GMP 20375/13421-0003[H]	GMPC	PROCTER & GAMBLE MANUFACTURA S.DE R.L. DE C.V., NAUCALPAN PLANT, SAN ANDRES ATOTO NO. 326, SAN FRANCISCO CUAUTLALPAN, NAUCALPAN DE JUAREZ, MX-53560, MEXICO	MEXICO	07/03/2011
UK GMP 23083 Insp GMP 23083/779272-0001[H]	GMPC	QILU PHARMACEUTICAL CO. LIMITED, WORKSHOP 4 (LINES 1 & 3), 849 DONGJIA TOWN, LICHENG DISTRICT, JINAN CITY, CN-250105, CHINA	CHINA	08/12/2008
UK GMP 33212 Insp GMP 33212/463341-0002[H]	GMPC	SINO-AMERICAN SMITHKLINE & FRENCH LABS LIMITED, CROSSING OF CHEN LIN ZHUANG AND CHENG ZHOU ROADS, DONG LI DISTRICT, TIANJIN, CN 300163, CHINA	CHINA	12/03/2008
UK GMP 25852 Insp GMP 25852/369939-0002[H]	GMPC	NEXCHEM PHARMACEUTICALS CO LIMITED, BAILONGQIAO INDUSTRIAL DISTRICT, JINHUA CITY, CN-321025, CHINA	CHINA	25/11/2007

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX